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ltrasound Energy Improves Myocardial
erfusion in the Presence of Coronary Occlusion
obert J. Siegel, MD, FACC,* Valentina N. Suchkova, MD,† Takashi Miyamoto, MD,* Huai Luo, MD,*
aymond B. Baggs, DVM, PHD,‡ Yoram Neuman, MD,* Michael Horzewski, BS,* Veijo Suorsa, PHD,*
ergio Kobal, MD,* Todd Thompson, BS,* Debra Echt, MD,* Charles W. Francis, MD†
os Angeles, California; and Rochester, New York
OBJECTIVES We evaluated whether ultrasound improves myocardial tissue perfusion in 14 animals with
coronary artery occlusion.
BACKGROUND A recent study demonstrated that low-frequency ultrasound improves tissue perfusion in the
rabbit ischemic limb, but there are no data on ultrasound enhancement of myocardial
perfusion.
METHODS Fourteen animals (9 dogs, 5 pigs) underwent thoracotomy and occlusion of a diagonal branch
of the left anterior descending coronary artery. Myocardial tissue perfusion units (TPUs) and
pH were measured before coronary occlusion, after occlusion, and after direct exposure of the
ischemic myocardium in the presence of fixed occlusion to low-frequency ultrasound (27
kHz).
RESULTS The TPU decreased from 100.9  13 at baseline to 71.1  13 (p  0.01) after 60 min
occlusion but rose by 19.7% to 85.1  8 (p  0.01) after ultrasound exposure for 60 min.
After 60-min coronary occlusion, myocardial pH fell from 7.43  14 to 7.05  0.15 (p 
0.01) but then improved to normal (7.46 0.32) after ultrasound for 60 min. Administration
of L-N-nitro-arginine methyl esther (L-NAME), an inhibitor of nitric oxide synthase,
before ultrasound exposure, blocked improvement in myocardial tissue perfusion and pH by
ultrasound. Quantitative histomorphology showed a significant increase in the capillary area
of myocardium exposed to ultrasound versus non-exposed myocardium (16.2  7.9 vs. 8.2 
2.1, p  0.02).
CONCLUSIONS Low-frequency, low-intensity ultrasound improves myocardial tissue perfusion and pH in the
presence of a fixed coronary artery occlusion. (J Am Coll Cardiol 2004;44:1454–8) © 2004
by the American College of Cardiology Foundationu
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Ehe goal of reperfusion therapy is to re-establish tissue
erfusion, whether using a noninvasive approach such as
hrombolytic therapy or an invasive strategy of percutaneous
oronary intervention. Investigators have pursued transcath-
ter ultrasound energy delivery for direct thrombus dissolu-
ion in vitro and in animal and human studies (1,2).
ltrasound has also been applied noninvasively to directly
isrupt thrombi in animals (3) and to facilitate clot lysis
ith thrombolytic drugs in both animals and humans (4,5).
ethods to improve myocardial tissue perfusion indepen-
ent of reperfusion would also be desirable for the treatment
f myocardial ischemia and infarction. Miyamoto et al. (6)
ound that noninvasive application of low-frequency ultra-
ound causes coronary arterial vasodilation. Recently, Such-
ova et al. (7,8) demonstrated that low-frequency, low-
ntensity ultrasound improves tissue perfusion in ischemic
abbit limbs through a nitric oxide (NO)-dependent mech-
nism. Consequently, we evaluated whether low-frequency
From the *Division of Cardiology, Cedars-Sinai Medical Center, Los Angeles,
alifornia; and †Hematology/Oncology Unit, Department of Medicine and ‡De-
artment of Pathology and Laboratory Medicine, University of Rochester School of
edicine, Rochester, New York. This study has been supported by Timi3 Systems
nc. (Santa Clara, California), of which Dr. Siegel is a consultant and stockholder.
Manuscript received January 7, 2004; revised manuscript received April 21, 2004,fccepted June 21, 2004.ltrasound improves myocardial tissue perfusion in the
etting of a fixed coronary occlusion.
ETHODS
tudies were performed according to the American Heart
ssociation’s position on research animal use. Nine dogs
nd five pigs were anesthetized and maintained by isoflurane
nhalation.
ltrasound device. The ultrasound system consists of a
enerator and an ultrasound transducer delivering 27-kHz,
ulsed-wave ultrasound (Timi3 Systems Inc., Santa Clara,
alifornia). Ultrasound, transmitted through a water-filled
ladder, was applied directly to the myocardium at the beam
aximum intensity of about 1.4 W/cm2 (corresponding to
patial-average, temporal-average intensity [ISATA] of about
.13 W/cm2) and a pulsed-wave duty cycle of 30%. The
ater-filled bladder was coupled to the myocardium with
ltrasound gel. The shape of the ultrasound field diverges
nd covers the entire heart. A calibrated hydrophone (model
103, Brüel & Kjaer, Naerum, Denmark) was used to
easure the output of the transducer. The ultrasound field
as previously been described elsewhere (6).
xperimental protocol (Fig. 1). Thoracotomy was per-ormed to expose the heart. Baseline measurements of
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October 6, 2004:1454–8 Ultrasound Improves Myocardial Perfusionyocardial perfusion were obtained with a laser Doppler
ow meter (BFL21, Transonic Systems, Ithaca, New York)
ith tissue perfusion units (TPUs) that are linearly related
o the red cell number multiplied by their velocity in the
easurement volume, as described previously (9). The light
enetrates the muscle about 1 mm, and the surface area
easured is 1 mm2. A pH meter (model HJ9023C, Hanna
ystems, Woonsocket, Rhode Island) was used to measure
yocardial pH (9).
After baseline measurements of myocardial TPU and pH,
he diagonal branch of the left anterior descending coronary
rtery perfusing that area of the heart was occluded with
ascular loops. Subsequently, the TPU, tissue pH, and
yocardial temperature beneath the ultrasound transducer
ere measured at 30 and 60 min.
After 60-min coronary occlusion, low-frequency pulsed
ltrasound (27 kHz, 30% duty cycle) was applied to the
yocardium subtended by the occluded coronary artery for
h. Ultrasound exposure was interrupted every 30 min to
easure TPU, pH, and temperature. In three dogs, L-N-
itro-arginine methyl esther (L-NAME) (50 mg/kg), an
nhibitor of NO synthase (NOS), was given intravenously
0 min before ultrasound exposure. The TPU and pH were
lso measured 30 min after completion of ultrasound expo-
ure. Subsequently, the coronary ligation was reversed, and
5 min later, TPU and pH were measured.
Two animals did not receive ultrasound and served as
Abbreviations and Acronyms
L-NAME  N-N-nitro-arginine methyl esther
NO  nitric oxide
NOS  nitric oxide synthase
TPU  tissue perfusion unit
igure 1. (A) The experimental protocol. The tissue perfusion unit (TPU),
H, and temperature were serially measured at baseline, 30 and 60 min
fter coronary occlusion, after 30 and 60 min of exposure, 30 min after
ltrasound (US) was stopped, and 15 min after opening the coronary artery
y release of the vascular loop. (B) Schematic shows the method of
oronary occlusion of the left anterior descending coronary artery (LAD)
iagonal (D) branch and site of ultrasound application, as well as TPU, pH,vnd temperature measurement. USD  ultrasound.ontrols, one of which received nitroglycerin. After coronary
cclusion, the nitroglycerin was titrated to reduce the
ystolic arterial pressure by 10 to 20 mm Hg.
istopathology. Animals were euthanized, and the myo-
ardium was fixed in 10% formalin. In each canine heart,
epresentative tissue blocks were taken from multiple sites
nexposed to ultrasound and exposed to ultrasound both
roximal and distal to the site of coronary ligation. Tissues
ere sectioned at 4 , stained with hematoxylin-eosin, and
xamined by an investigator (Dr. Baggs), who was blinded
s to the site and pretreatment. Transverse histologic
ections of muscle tissue were examined using an Olympus
H-2 photomicroscope with a SPOT high-resolution cam-
ra coupled to Image-Pro Plus software. Calibration utilized
n American Optical stage micrometer. Using the tracing
ool, the circumference of 10 capillaries was measured,
ectioned at 5 , and stained with hematoxylin-eosin.
tatistical analysis. All data are presented as the mean
alue  SD. Overall comparisons of the time course of
hanges in TPU, pH, and temperature were performed by
epeated measures analysis of variance (ANOVA). If the
verall ANOVA model was significant, then paired t tests
ere used to assess the change between specific time points
baseline to 30 min of occlusion, baseline to 60 min of
cclusion, 60 min of occlusion to 30 min of ultrasound, and
0 min of occlusion to 60 min of ultrasound). Change in
apillary area was also assessed by the paired t test. A
ignificance level of 0.05 was used for all tests. No adjust-
ent for multiple comparisons was made.
ESULTS
igure 2A demonstrates the tissue perfusion data on eight
ogs and four pigs at baseline, 30 and 60 min after coronary
rtery ligation, 30 and 60 min after ultrasound exposure, 30
in after stopping ultrasound, and 15 min after re-
stablishing coronary flow by releasing the vascular loop.
he baseline TPU of 104.8  14 fell to 79.4  13 after 30
in and to 73.1  13 (p  0.05) after 60-min occlusion.
fter application of low-intensity, 27-kHz ultrasound, tis-
ue perfusion increased by 18.9%, from 73.1 13 to 86.9
4 (p  0.05). Thirty minutes after termination of ultra-
ound exposure, TPU again declined to pre-ultrasound
alues of 73.4  9. Restoration of coronary flow by release
f the vascular loop resulted in an increase in TPU to 97 
1. As shown in Figure 2B, the myocardial pH fell from a
aseline value of 7.44  0.13 to 7.20  0.08 after 30 min
nd to 7.06  0.21 after 60-min coronary occlusion (p 
.05). As with TPU, the pH rose after application of
ltrasound to 7.36  0.26 (p  0.05) after 30 min and after
0 min of ultrasound to 7.44  0.30 (p  0.05). Unlike
PU, however, 30 min after stopping ultrasound, the pH
emained elevated above the pre-ultrasound level (7.28 
.29 vs. 7.06  0.21), but less than the 60-min ultrasound
alue (7.28  0.29 vs. 7.44  0.30) After opening the
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Ultrasound Improves Myocardial Perfusion October 6, 2004:1454–8igation, the pH value (7.44  0.12) was similar to that at
aseline and during ultrasound exposure.
In Figures 2C and 2D, data on each species (dogs and
igs) are plotted separately for myocardial TPU and pH.
he TPU and pH behaved similarly in dogs and pigs after
oronary occlusion, ultrasound exposure, and after release of
oronary ligation. Ultrasound induced a significant increase
n perfusion and pH in both species (p  0.05).
Three dogs were pretreated with L-NAME 10 min before
ltrasound exposure to inhibit NOS. As demonstrated in
igures 2A and 2B, the application of ultrasound to isch-
mic myocardium in these animals resulted in no improve-
ent in tissue perfusion, as measured by TPU (46.8  13
s. 44.9  5) or pH (7.10  0.03 vs. 7.07  0.03). In
ddition, 30 min after reversal of coronary occlusion by
emoval of the ligature, the baseline myocardial tissue
erfusion (TPU: 46.8  13 vs. 55.2  13) and pH (7.10 
.03 vs. 7.16  0.06) were not re-established.
Two animals served as controls and received no ultra-
ound exposure. After coronary occlusion, there was no
igure 2. The myocardial tissue perfusion unit (TPU) (A and C) and pH
nd 60 min of ultrasound exposure, 30 min after stopping ultrasound, and
rom eight dogs and four pigs. The hashed lines demonstrate the results w
ata for each species (dogs and pigs). The thin line indicates dog data, an
ltrasound at 30 or 60 min and after opening the coronary artery.pontaneous improvement in perfusion or pH. In one dog Peceiving intravenous nitroglycerin, tissue perfusion and pH
id not improve after 30, 60, or 90 min.
istopathology. As shown in Figures 3A and 3B, there is
ilation (increase in circumference) of capillaries in
ltrasound-exposed myocardium. By quantitative histomor-
hology, the mean capillary area significantly increased from
.2  2.1 to 16.2  7.9 mm2 in the ultrasound-exposed
yocardium (p  0.02). This increase in capillary area,
owever, was blocked by the administration of the NOS
nhibitor L-NAME (Fig. 3C).
hermal analysis. The myocardial temperature beneath
he ultrasound transducer was monitored continuously. At
aseline, the temperature was 36.5  0.4°C; after 30 min of
ltrasound, it was 35.5  0.5°C; and after 60 min of
ltrasound, it was 35.7  1.2°C (p  NS).
ISCUSSION
his is the first study demonstrating that low-frequency,
ow-intensity ultrasound improves myocardial tissue perfu-
ion in the presence of a fixed coronary artery occlusion.
nd D) are shown at baseline, 30 and 60 min after coronary occlusion, 30
in after opening the coronary artery. Panels A and B are combined data
he animal (three dogs) was pretreated with L-NAME. C and D show the
thick line is for pig data. *p  0.05 for 60-min occlusion versus during(B a
15 m
hen t
d therevious work has shown that low-frequency ultrasound
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October 6, 2004:1454–8 Ultrasound Improves Myocardial Perfusionnergy applied transthoracically has a significant coronary
asodilator effect in dogs (6). As in the rabbit peripheral
rtery studies of Suchkova et al. (7,8), we found that
pplication of ultrasound in both a canine and porcine
odel resulted in enhanced myocardial tissue perfusion, as
easured by both laser Doppler capillary flow and tissue
H, despite persistent coronary artery occlusion. Because
ogs have a more robust collateral circulation than do
umans, we thought it was important to also corroborate
ur findings in pigs, which, like humans, lack an innate
ollateral circulation (10). Of note, after ultrasound, the
PU rose to 85% of their baseline value, and the pH
ormalized to 7.40, a level at which cells are likely to be
iable and functional. Ultrasound-enhanced perfusion in the
etting of epicardial coronary artery occlusion was associated
ith histologic evidence of an increase in capillary circum-
igure 3. Sections of canine left ventricular myocardium: (a) not exposed
o ultrasound; (b) exposed to 60-min ultrasound; and (c) from a dog
retreated with L-NAME and then exposed to 60-min ultrasound. Note
he size (circumference) of the capillaries (arrows) is larger in the area
xposed to ultrasound (b) than in the control (a) and the dog pretreated
ith L-NAME (c). Bar  50 ; hematoxylin-eosin stain. C  capillary.erence or dilation. As in the previous study on peripheral ruscle (7), this effect was related to the synthesis of NO
ecause an inhibitor of NOS blocked the ultrasound in-
rease in tissue perfusion, improvement in pH, and increase
n myocardial capillary size.
The mechanism(s) by which low-frequency ultrasound
mproves tissue perfusion is complex. Low-frequency ultra-
ound dilates epicardial coronary arteries as well as periph-
ral arteries (11–13). Ultrasound generates pressure waves,
hich impart mechanical energy to the tissues (7). The
bserved non-thermal vasodilation by ultrasound is likely to
e due to a direct vasodilator effect related to oscillation or
urbulent shear stress. Alterations of the endothelial cell
echanoreceptors may thus promote the release of NO
14). The primary role of NO for enhancing tissue perfu-
ion, despite epicardial coronary occlusion, is supported by
he blocking effect of L-NAME. This finding is consistent
ith studies of peripheral limbs in which inhibition of NOS
lso eliminated any ultrasound augmentation of muscle
erfusion (7,8). A range of L-NAME concentrations have
een used to successfully block NOS. In this study, we used
similar dose of L-NAME, as used in previous reports.
-NAME, at the concentration used (50 mg/kg), blocks
ltrasound-induced upregulation of NOS (7,8,15–20).
herefore, ultrasound-enhanced myocardial tissue perfusion
n the setting of coronary occlusion is likely to be due to
O-mediated enhancement of coronary artery collateral
ow. Tissue perfusion, as measured in TPU, decreased to
0% of baseline after arterial occlusion but rose to 85% of
re-occlusion levels during ultrasound exposure. This find-
ng, together with the significant increase in tissue pH and
ncrease in capillary area after ultrasound, are consistent
ith an increase in collateral flow to the ischemic zone.
Multiple studies have demonstrated that ultrasound has a
asodilator effect. Catheter-delivered low-frequency ultra-
ound has been shown to induce arterial vasodilation ex vivo
n the rabbit aorta, in canine coronary arteries, and also in a
linical study in which patients were treated with peripheral
rterial ultrasound angioplasty as well as in patients with
eripheral arterial vasospasm (12,13). Two previous studies
n rabbit limbs have demonstrated ultrasound-enhanced
erfusion in the setting of complete arterial occlusion (7,8),
ia an NO-dependent mechanism. Our findings are consis-
ent with previous studies but extend these observations to
he critical setting of acute myocardial ischemia from
picardial corononary artery occlusion.
Transcatheter ultrasound energy has been used effectively
o directly disrupt thrombi in vitro and in vivo in animals
nd in humans (1,2,20,22). More recently, the noninvasive
pplication of ultrasound has been developed for thrombus
emoval. Rosenschein et al. (3) have successfully applied
igh-intensity, focused ultrasound for site-specific throm-
us destruction in vivo and in a porcine model. We have
hown that low-frequency, low-intensity ultrasound speeds
he rate and efficacy of thrombolytic drugs in vitro and in
nimal studies (4,8,20,23–26). A pilot study has corrobo-
ated the safety and feasibility of using low-frequency
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Ultrasound Improves Myocardial Perfusion October 6, 2004:1454–8ltrasound to augment coronary thrombolysis in patients
ith acute myocardial infarction (5). The findings of the
urrent study indicate that ultrasound energy alone can
mprove tissue perfusion and reverse acidosis. Consequently,
ltrasound therapy has substantial promise as therapy for
atients with acute coronary syndromes (with or without a
hrombolytic drug) and for the treatment of chronic myo-
ardial ischemia.
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